CRS is a systemic inflammatory response occurring within few weeks of drug administration due to a massive T cell stimulation with consequent cytokine storm (including IL-6, IL-2R, IL-10, IFN-γ, and TNF-α). The gene discussed is IL2RA; the disease is congenital rubella syndrome.